{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:00:51Z","timestamp":1785416451901,"version":"3.56.0"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"crossref","award":["QU-APC-2026"],"award-info":[{"award-number":["QU-APC-2026"]}],"id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"crossref"}]},{"award":["QU-APC-2026"],"award-info":[{"award-number":["QU-APC-2026"]}],"id":[{"id":"https:\/\/ror.org\/01wsfe280","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The Middle East Respiratory Syndrome coronavirus (MERS-CoV) remains a significant global health concern due to the absence of approved antiviral therapeutics. In this study, we developed a ligand-based machine learning framework to identify potential inhibitors of the MERS-CoV main protease (Mpro) using molecular representations derived from SMILES strings. Multiple classification algorithms, including logistic regression, support vector machines, random forests, and Extreme Gradient Boosting (XGBoost), were systematically evaluated. Model performance was assessed through both internal validation and an external dataset. While several models exhibited strong performance during validation, the Random Forest classifier demonstrated the most robust and consistent generalization, achieving superior predictive performance on the external dataset. To ensure model reliability, a comprehensive validation strategy was implemented, including strict data partitioning to prevent structural overlap, Y-scrambling analysis to eliminate chance correlations, and applicability domain assessment to define the model\u2019s reliable prediction space. The final model was deployed as an interactive web-based application, enabling rapid virtual screening of compounds through single or batch SMILES input, and providing activity predictions along with probability scores and selected physicochemical descriptors. Overall, this study presents a reproducible ligand-based approach for supporting the early-stage identification of potential MERS-CoV Mpro inhibitors.<\/jats:p>","DOI":"10.3390\/ijms27094107","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:57:29Z","timestamp":1777967849000},"page":"4107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MERS-Mpro Predictor: A Machine Learning-Based Tool for Rapid Screening of Potential MERS-CoV Main Protease Inhibitors"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-0949","authenticated-orcid":false,"given":"Mebarka","family":"Ouassaf","sequence":"first","affiliation":[{"name":"Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, Biskra 07000, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0871-6313","authenticated-orcid":false,"given":"Bader Y.","family":"Alhatlani","sequence":"additional","affiliation":[{"name":"Unit of Scientific Research, Applied College, Qassim University, Buraydah 52571, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.medmal.2019.10.004","article-title":"Focus on Middle East Respiratory Syndrome Coronavirus (MERS-CoV)","volume":"50","author":"Bleibtreu","year":"2020","journal-title":"M\u00e9d. Mal. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: Recent Insights into Emerging Coronaviruses","volume":"14","author":"Falzarano","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhin.2016.10.008","article-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Outbreak in South Korea, 2015: Epidemiology, Characteristics and Public Health Implications","volume":"95","author":"Kim","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1039\/D2MD00344A","article-title":"Advances in Research on 3C-like Protease (3CLpro) Inhibitors against SARS-CoV-2 since 2020","volume":"14","author":"Chen","year":"2023","journal-title":"RSC Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zag\u00f3rska, A., Czopek, A., Fryc, M., and Jo\u0144czyk, J. (2024). Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents. Biomolecules, 14.","DOI":"10.3390\/biom14070797"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 Main Protease (Mpro): Structure, Function, and Emerging Therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and Discovery of Its Inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chtita, S., Belaidi, S., Qais, F.A., Ouassaf, M., AlMogren, M.M., Al-Zahrani, A.A., Bakhouch, M., Belhassan, A., Zaki, H., and Bouachrine, M. (2022). Unsymmetrical Aromatic Disulfides as SARS-CoV-2 Mpro Inhibitors: Molecular Docking, Molecular Dynamics, and ADME Scoring Investigations. J. King Saud Univ.\u2014Sci., 34.","DOI":"10.1016\/j.jksus.2022.102226"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.crgsc.2021.100202","article-title":"In Silico Screening of Antiviral Compounds from Moringa Oleifera for Inhibition of SARS-CoV-2 Main Protease","volume":"4","author":"Sivani","year":"2021","journal-title":"Curr. Res. Green Sustain. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4067\/S0717-97072022000305602","article-title":"Targeting the main protease and the spike protein of SARS-CoV-2 with naturally occurring compounds from some Cameroonian medicinal plants: An in-silico study for drug designing","volume":"67","author":"Fouedjou","year":"2022","journal-title":"J. Chil. Chem. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.37201\/req\/002.2022","article-title":"Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination","volume":"35","author":"Reina","year":"2022","journal-title":"Rev. Esp. Quim. Publ. Soc. Esp. Quim."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12985-024-02607-4","article-title":"Targeting SARS-CoV-2 Main Protease: A Comprehensive Approach Using Advanced Virtual Screening, Molecular Dynamics, and in Vitro Validation","volume":"21","author":"Gevorgyan","year":"2024","journal-title":"Virol. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.csbj.2025.12.033","article-title":"Machine Learning for Drug-Target Interaction Prediction: A Comprehensive Review of Models, Challenges, and Computational Strategies","volume":"31","author":"Ahmad","year":"2026","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44395-025-00007-3","article-title":"Artificial Intelligence in Drug Discovery and Development: Transforming Challenges into Opportunities","volume":"1","author":"Kant","year":"2025","journal-title":"Discov. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10822-025-00717-x","article-title":"DeepTargetClass: A Web-Based Platform for Predicting Protein Target Classes of Small Molecules","volume":"40","author":"Ouassaf","year":"2025","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11030-023-10601-1","article-title":"Machine Learning Combines Atomistic Simulations to Predict SARS-CoV-2 Mpro Inhibitors from Natural Compounds","volume":"28","author":"Nguyen","year":"2023","journal-title":"Mol. Divers."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bi, X., Wang, Y., Wang, J., and Liu, C. (2025). Machine Learning for Multi-Target Drug Discovery: Challenges and Opportunities in Systems Pharmacology. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17091186"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ouassaf, M., Mazri, R., Khan, S.U., Rengasamy, K.R.R., Alhatlani, B.Y., Ouassaf, M., Mazri, R., Khan, S.U., Rengasamy, K.R.R., and Alhatlani, B.Y. (2025). Machine Learning-Guided Screening and Molecular Docking for Proposing Naturally Derived Drug Candidates Against MERS-CoV 3CL Protease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073047"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ci700157b","article-title":"Y-Randomization and Its Variants in QSPR\/QSAR","volume":"47","author":"Meringer","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best Practices for QSAR Model Development, Validation, and Exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol. Inform."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41512-024-00177-1","article-title":"Understanding Overfitting in Random Forest for Probability Estimation: A Visualization and Simulation Study","volume":"8","author":"Dhiman","year":"2024","journal-title":"Diagn. Progn. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Imani, M., Beikmohammadi, A., and Arabnia, H.R. (2025). Comprehensive Analysis of Random Forest and XGBoost Performance with SMOTE, ADASYN, and GNUS Under Varying Imbalance Levels. Technologies, 13.","DOI":"10.20944\/preprints202501.2274.v1"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine Learning in Drug Discovery: A Review","volume":"55","author":"Dara","year":"2022","journal-title":"Artif. Intell. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An Oral SARS-CoV-2 Mpro Inhibitor Clinical Candidate for the Treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved \u03b1-Ketoamide Inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline Coronavirus Drug Inhibits the Main Protease of SARS-CoV-2 and Blocks Virus Replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-Based Design of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The Resurgence of Covalent Drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of Fluorine in Medicinal Chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Vel\u00e1squez-Bedoya, P.A., Zapata-Cardona, M.I., Monsalve-Escudero, L.M., Perea\u00f1ez, J.A., Guerra-Arias, D., Pastrana-Restrepo, M., Galeano, E., and Zapata-Builes, W. (2025). Antiviral Activity of Halogenated Compounds Derived from L-Tyrosine Against SARS-CoV-2. Molecules, 30.","DOI":"10.3390\/molecules30071419"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","article-title":"An Overview of Severe Acute Respiratory Syndrome\u2013Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy","volume":"59","author":"Pillaiyar","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL Bioactivity Database: An Update","volume":"42","author":"Bento","year":"2014","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/4107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:15:47Z","timestamp":1778040947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/4107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27094107"],"URL":"https:\/\/doi.org\/10.3390\/ijms27094107","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}